Kyphon Newswire (Page 6)

Kyphon Newswire (Page 6)

Comprehensive Real-Time News Feed for Kyphon. (Page 6)

Results 101 - 120 of 3,221 in Kyphon

  1. Medtronic plc. (MDT) Given "Buy" Rating at Needham & Company LLCRead the original story w/Photo

    May 25, 2017 | AmericanBankingNews.com

    's stock had its "buy" rating reaffirmed by equities research analysts at Needham & Company LLC in a research note issued on Thursday. They currently have a $95.00 price target on the medical technology company's stock.

    Comment?

  2. Medtronic 4Q profit tops Wall Street forecastsRead the original story

    May 25, 2017 | The Oak Ridge Observer

    Evercore ISI's price objective points to a potential upside of 4.49% from the stock's previous close. MDT has been the subject of a number of recent research reports.

    Comment?

  3. Medtronic plc.'s (MDT) Buy Rating Reiterated at Oppenheimer Holdings Inc.Read the original story w/Photo

    May 25, 2017 | Daily Political

    MDT has been the topic of several other research reports. Goldman Sachs Group Inc started coverage on Medtronic plc.

    Comment?

  4. Medtronic : U.S. Patents Awarded to Inventors in ArizonaRead the original story

    May 25, 2017 | World News Report

    ALEXANDRIA, Va., May 25 -- The following federal patents were awarded to inventors in Arizona.

    Comment?

  5. Jefferies Group Research Analysts Lower Earnings Estimates for Medtronic plc.Read the original story w/Photo

    May 25, 2017 | AmericanBankingNews.com

    Research analysts at Jefferies Group cut their Q3 2018 earnings per share estimates for Medtronic plc. in a research report issued to clients and investors on Tuesday.

    Comment?

  6. Medtronic plc. (MDT) Releases Earnings Results, Beats Expectations By $0.02 EPSRead the original story w/Photo

    May 25, 2017 | AmericanBankingNews.com

    Medtronic plc. released its quarterly earnings results on Thursday. The medical technology company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.31 by $0.02.

    Comment?

  7. Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial ResultsRead the original story w/Photo

    May 25, 2017 | PR-inside.com

    May 25, 2107 - Medtronic plc today announced financial results for its fourth quarter and fiscal year 2017, which ended April 28, 2017. The company reported fourth quarter worldwide revenue of $7.916 billion, compared to the $7.567 billion reported in the fourth quarter of fiscal year 2016, an increase of 5 percent on both a reported and constant currency basis.

    Comment?

  8. Euro Ressources : Appointment of the Chairman of the Board of Directors and Declaration of DividendRead the original story w/Photo

    May 24, 2017 | PR-inside.com

    PARIS, France, May 24, 2017: EURO Ressources S.A. reports effective May 24, 2017, Mr. David Watkins was reappointed as Chairman of the board of directors of EURO by the board of directors after the shareholders meeting. As well, EURO reports that the annual ordinary general meeting of shareholders held May 24, 2017 has determined that a dividend in the amount of a 0.15 per ordinary share will be paid to the Company's shareholders.

    Comment?

  9. Atos SE Ordinary General MeetingRead the original story w/Photo

    May 24, 2017 | PR-inside.com

    Bezons, On May 24, 2017 - Atos SE held today its Annual General Meeting chaired by Mr. Thierry Breton, Chairman and Chief Executive Officer of the Company. The Group presented record results performed in 2016, for revenue growth, order entries, operational profitability, net result and free cash flow.

    Comment?

  10. Medtronic Chairman and CEO Omar Ishrak to Speak at Goldman Sachs Global Healthcare ConferenceRead the original story

    May 24, 2017 | GlobeNewswire

    May 24, 2017 - Medtronic plc , the global leader in medical technology, today announced that it will participate in the 38th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 13, 2017, in Rancho Palos Verdes, Calif. Omar Ishrak, chairman and chief executive officer of Medtronic, will answer questions about the company beginning at 10:40 a.m. PDT .

    Comment?

  11. Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access...Read the original story w/Photo

    May 24, 2017 | PR-inside.com

    May 24, 2017 - Medtronic plc today announced that the first patient has been enrolled in the IN.PACT AV Access Drug-Coated Balloon study for use in patients with end-stage renal disease . The U.S. Food and Drug Administration approved the investigational device exemption study to evaluate the safety and efficacy of IN.PACT AV Access DCB as a treatment for failing arteriovenous fistulas in ESRD patients.

    Comment?

  12. Dupont Capital Management Corp Sells 171,144 Shares of Medtronic plc.Read the original story w/Photo

    May 24, 2017 | Daily Political

    DUPONT CAPITAL MANAGEMENT Corp cut its position in Medtronic plc. by 74.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission.

    Comment?

  13. Medtronic plc. (MDT) Position Maintained by Regent Investment Management LLCRead the original story w/Photo

    May 23, 2017 | IntersportsWire

    Regent Investment Management LLC continued to hold its stake in Medtronic plc. during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

    Comment?

  14. Medtronic plc. (MDT) Receives Consensus Recommendation of "Hold" from BrokeragesRead the original story w/Photo

    May 23, 2017 | AmericanBankingNews.com

    Medtronic plc. has received an average rating of "Hold" from the twenty-seven research firms that are covering the stock.

    Comment?

  15. Medtronic plc. (MDT) Earns Coverage Optimism Rating of 0.25Read the original story w/Photo

    May 23, 2017 | The Breeze

    News articles about Medtronic plc. have trended somewhat positive this week, AlphaOne Sentiment Analysis reports.

    Comment?

  16. Medtronic plc. (MDT) Downgraded to "Sell" at Zacks Investment ResearchRead the original story w/Photo

    May 23, 2017 | AmericanBankingNews.com

    According to Zacks, "Ahead of its fourth quarter fiscal 2017 result, we believe Medtronic will do well banking on strong performances of major business groups with sustainability across all regions. Earlier, the company observed solid growth trend in the U.S. on healthy global acceptance of its therapies.

    Comment?

  17. NJ State Employees Deferred Compensation Plan Holds Stake in Medtronic plc.Read the original story w/Photo

    May 23, 2017 | IntersportsWire

    NJ State Employees Deferred Compensation Plan continued to hold its position in shares of Medtronic plc. during the first quarter, according to its most recent disclosure with the SEC.

    Comment?

  18. 494,010 Shares in Medtronic plc. (MDT) Acquired by Hexavest Inc.Read the original story w/Photo

    May 22, 2017 | IntersportsWire

    Hexavest Inc. purchased a new stake in shares of Medtronic plc. during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission .

    Comment?

  19. Medtronic Resolute Onyx(TM) 2.0 mm Clinical Study Meets Primary...Read the original story

    May 18, 2017 | PressReleasePoint

    Medtronic plc today announced that the Resolute Onyx Drug-Eluting Stent met its primary endpoint of Target Lesion Failure at one year for the treatment of coronary artery disease in extra-small vessels. Results from the RESOLUTE ONYX 2.0 mm Clinical Study were presented today as a Hot Line/Late-Breaking Trial Session at the 2017 EuroPCR Annual Meeting and simultaneously published in the Journal of the American College of Cardiology : Cardiovascular Intervention .

    Comment?

  20. Medtronic plc. (MDT) Now Covered by Goldman Sachs Group IncRead the original story w/Photo

    May 18, 2017 | Daily Political

    The firm set a "neutral" rating and a $87.00 price target on the medical technology company's stock. Goldman Sachs Group Inc's price objective indicates a potential upside of 5.25% from the stock's current price.

    Comment?